カテゴリー： 世界, 医療/バイオ, LP Information

世界のペット用狂犬病ウイルスワクチン市場予測 2023年-2029年

【英語タイトル】Global Rabies Virus Vaccine for Pets Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC04325）・商品コード：LP23DC04325
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：107
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のペット用狂犬病ウイルスワクチン市場」は、過去の販売実績から2022年の世界のペット用狂犬病ウイルスワクチンの総販売量を検討し、2023年から2029年の予測されるペット用狂犬病ウイルスワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のペット用狂犬病ウイルスワクチンの市場規模を掲載し、XXX百万米ドル規模の世界のペット用狂犬病ウイルスワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界のペット用狂犬病ウイルスワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のペット用狂犬病ウイルスワクチン市場における各社の独自のポジションをより深く理解するために、ペット用狂犬病ウイルスワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のペット用狂犬病ウイルスワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ペット用狂犬病ウイルスワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ペット用狂犬病ウイルスワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ペット用狂犬病ウイルスワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ペット用狂犬病ウイルスワクチンの世界主要メーカーとしては、Merck Animal Health、 Zoetis、 Indian Immunologicals、 Merial、 Boehringer Ingleheim Vetmedica、 Elanco、 MSD Animal Health、 Biogenesis Bago、 Virbac、 Heska、 Hipraなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のペット用狂犬病ウイルスワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではペット用狂犬病ウイルスワクチン市場をセグメンテーションし、種類別 (不活化ウイルスワクチン、改変生ウイルスワクチン、組換えワクチン、その他)、用途別 (家庭、商業)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：不活化ウイルスワクチン、改変生ウイルスワクチン、組換えワクチン、その他

・用途別区分：家庭、商業

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のペット用狂犬病ウイルスワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見たペット用狂犬病ウイルスワクチン市場成長の要因は何か？
・ペット用狂犬病ウイルスワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ペット用狂犬病ウイルスワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ペット用狂犬病ウイルスワクチンの年間販売量2018-2029、地域別現状・将来分析
・ペット用狂犬病ウイルスワクチンの種類別セグメント：不活化ウイルスワクチン、改変生ウイルスワクチン、組換えワクチン、その他
・ペット用狂犬病ウイルスワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ペット用狂犬病ウイルスワクチンの用途別セグメント：家庭、商業
・ペット用狂犬病ウイルスワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のペット用狂犬病ウイルスワクチン市場
・企業別のグローバルペット用狂犬病ウイルスワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のペット用狂犬病ウイルスワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別のペット用狂犬病ウイルスワクチン販売価格
・主要企業のペット用狂犬病ウイルスワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ペット用狂犬病ウイルスワクチンの地域別レビュー
・地域別のペット用狂犬病ウイルスワクチン市場規模2018-2023：年間販売量、売上
・主要国別のペット用狂犬病ウイルスワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカのペット用狂犬病ウイルスワクチン販売の成長
・アジア太平洋のペット用狂犬病ウイルスワクチン販売の成長
・ヨーロッパのペット用狂犬病ウイルスワクチン販売の成長
・中東・アフリカのペット用狂犬病ウイルスワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別のペット用狂犬病ウイルスワクチン販売量、売上（2018-2023）
・南北アメリカのペット用狂犬病ウイルスワクチンの種類別販売量
・南北アメリカのペット用狂犬病ウイルスワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のペット用狂犬病ウイルスワクチン販売量、売上（2018-2023）
・アジア太平洋のペット用狂犬病ウイルスワクチンの種類別販売量
・アジア太平洋のペット用狂犬病ウイルスワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のペット用狂犬病ウイルスワクチン販売量、売上（2018-2023）
・ヨーロッパのペット用狂犬病ウイルスワクチンの種類別販売量
・ヨーロッパのペット用狂犬病ウイルスワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のペット用狂犬病ウイルスワクチン販売量、売上（2018-2023）
・中東・アフリカのペット用狂犬病ウイルスワクチンの種類別販売量
・中東・アフリカのペット用狂犬病ウイルスワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ペット用狂犬病ウイルスワクチンの製造コスト構造分析
・ペット用狂犬病ウイルスワクチンの製造プロセス分析
・ペット用狂犬病ウイルスワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ペット用狂犬病ウイルスワクチンの主要なグローバル販売業者
・ペット用狂犬病ウイルスワクチンの主要なグローバル顧客

地域別のペット用狂犬病ウイルスワクチン市場予測レビュー
・地域別のペット用狂犬病ウイルスワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ペット用狂犬病ウイルスワクチンの種類別市場規模予測
・ペット用狂犬病ウイルスワクチンの用途別市場規模予測

主要企業分析
Merck Animal Health、 Zoetis、 Indian Immunologicals、 Merial、 Boehringer Ingleheim Vetmedica、 Elanco、 MSD Animal Health、 Biogenesis Bago、 Virbac、 Heska、 Hipra
・企業情報
・ペット用狂犬病ウイルスワクチン製品
・ペット用狂犬病ウイルスワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Rabies Virus Vaccine for Pets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rabies Virus Vaccine for Pets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rabies Virus Vaccine for Pets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rabies Virus Vaccine for Pets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rabies Virus Vaccine for Pets players cover Merck Animal Health, Zoetis, Indian Immunologicals, Merial, Boehringer Ingleheim Vetmedica, Elanco, MSD Animal Health, Biogenesis Bago and Virbac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Rabies Virus Vaccine for Pets Industry Forecast” looks at past sales and reviews total world Rabies Virus Vaccine for Pets sales in 2022, providing a comprehensive analysis by region and market sector of projected Rabies Virus Vaccine for Pets sales for 2023 through 2029. With Rabies Virus Vaccine for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Virus Vaccine for Pets industry.
This Insight Report provides a comprehensive analysis of the global Rabies Virus Vaccine for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Virus Vaccine for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rabies Virus Vaccine for Pets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Virus Vaccine for Pets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Virus Vaccine for Pets.
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Virus Vaccine for Pets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Inactivated Virus Vaccine
Modified Live Virus Vaccine
Recombinant Vaccine
Others
Segmentation by application
Household Use
Commercial Use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck Animal Health
Zoetis
Indian Immunologicals
Merial
Boehringer Ingleheim Vetmedica
Elanco
MSD Animal Health
Biogenesis Bago
Virbac
Heska
Hipra
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rabies Virus Vaccine for Pets market?
What factors are driving Rabies Virus Vaccine for Pets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Virus Vaccine for Pets market opportunities vary by end market size?
How does Rabies Virus Vaccine for Pets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rabies Virus Vaccine for Pets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rabies Virus Vaccine for Pets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rabies Virus Vaccine for Pets by Country/Region, 2018, 2022 & 2029
2.2 Rabies Virus Vaccine for Pets Segment by Type
2.2.1 Inactivated Virus Vaccine
2.2.2 Modified Live Virus Vaccine
2.2.3 Recombinant Vaccine
2.2.4 Others
2.3 Rabies Virus Vaccine for Pets Sales by Type
2.3.1 Global Rabies Virus Vaccine for Pets Sales Market Share by Type (2018-2023)
2.3.2 Global Rabies Virus Vaccine for Pets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rabies Virus Vaccine for Pets Sale Price by Type (2018-2023)
2.4 Rabies Virus Vaccine for Pets Segment by Application
2.4.1 Household Use
2.4.2 Commercial Use
2.5 Rabies Virus Vaccine for Pets Sales by Application
2.5.1 Global Rabies Virus Vaccine for Pets Sale Market Share by Application (2018-2023)
2.5.2 Global Rabies Virus Vaccine for Pets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rabies Virus Vaccine for Pets Sale Price by Application (2018-2023)
3 Global Rabies Virus Vaccine for Pets by Company
3.1 Global Rabies Virus Vaccine for Pets Breakdown Data by Company
3.1.1 Global Rabies Virus Vaccine for Pets Annual Sales by Company (2018-2023)
3.1.2 Global Rabies Virus Vaccine for Pets Sales Market Share by Company (2018-2023)
3.2 Global Rabies Virus Vaccine for Pets Annual Revenue by Company (2018-2023)
3.2.1 Global Rabies Virus Vaccine for Pets Revenue by Company (2018-2023)
3.2.2 Global Rabies Virus Vaccine for Pets Revenue Market Share by Company (2018-2023)
3.3 Global Rabies Virus Vaccine for Pets Sale Price by Company
3.4 Key Manufacturers Rabies Virus Vaccine for Pets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Virus Vaccine for Pets Product Location Distribution
3.4.2 Players Rabies Virus Vaccine for Pets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rabies Virus Vaccine for Pets by Geographic Region
4.1 World Historic Rabies Virus Vaccine for Pets Market Size by Geographic Region (2018-2023)
4.1.1 Global Rabies Virus Vaccine for Pets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rabies Virus Vaccine for Pets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rabies Virus Vaccine for Pets Market Size by Country/Region (2018-2023)
4.2.1 Global Rabies Virus Vaccine for Pets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rabies Virus Vaccine for Pets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rabies Virus Vaccine for Pets Sales Growth
4.4 APAC Rabies Virus Vaccine for Pets Sales Growth
4.5 Europe Rabies Virus Vaccine for Pets Sales Growth
4.6 Middle East & Africa Rabies Virus Vaccine for Pets Sales Growth
5 Americas
5.1 Americas Rabies Virus Vaccine for Pets Sales by Country
5.1.1 Americas Rabies Virus Vaccine for Pets Sales by Country (2018-2023)
5.1.2 Americas Rabies Virus Vaccine for Pets Revenue by Country (2018-2023)
5.2 Americas Rabies Virus Vaccine for Pets Sales by Type
5.3 Americas Rabies Virus Vaccine for Pets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Virus Vaccine for Pets Sales by Region
6.1.1 APAC Rabies Virus Vaccine for Pets Sales by Region (2018-2023)
6.1.2 APAC Rabies Virus Vaccine for Pets Revenue by Region (2018-2023)
6.2 APAC Rabies Virus Vaccine for Pets Sales by Type
6.3 APAC Rabies Virus Vaccine for Pets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rabies Virus Vaccine for Pets by Country
7.1.1 Europe Rabies Virus Vaccine for Pets Sales by Country (2018-2023)
7.1.2 Europe Rabies Virus Vaccine for Pets Revenue by Country (2018-2023)
7.2 Europe Rabies Virus Vaccine for Pets Sales by Type
7.3 Europe Rabies Virus Vaccine for Pets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rabies Virus Vaccine for Pets by Country
8.1.1 Middle East & Africa Rabies Virus Vaccine for Pets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rabies Virus Vaccine for Pets Revenue by Country (2018-2023)
8.2 Middle East & Africa Rabies Virus Vaccine for Pets Sales by Type
8.3 Middle East & Africa Rabies Virus Vaccine for Pets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Virus Vaccine for Pets
10.3 Manufacturing Process Analysis of Rabies Virus Vaccine for Pets
10.4 Industry Chain Structure of Rabies Virus Vaccine for Pets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Virus Vaccine for Pets Distributors
11.3 Rabies Virus Vaccine for Pets Customer
12 World Forecast Review for Rabies Virus Vaccine for Pets by Geographic Region
12.1 Global Rabies Virus Vaccine for Pets Market Size Forecast by Region
12.1.1 Global Rabies Virus Vaccine for Pets Forecast by Region (2024-2029)
12.1.2 Global Rabies Virus Vaccine for Pets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rabies Virus Vaccine for Pets Forecast by Type
12.7 Global Rabies Virus Vaccine for Pets Forecast by Application
13 Key Players Analysis
13.1 Merck Animal Health
13.1.1 Merck Animal Health Company Information
13.1.2 Merck Animal Health Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.1.3 Merck Animal Health Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Animal Health Main Business Overview
13.1.5 Merck Animal Health Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.2.3 Zoetis Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Indian Immunologicals
13.3.1 Indian Immunologicals Company Information
13.3.2 Indian Immunologicals Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.3.3 Indian Immunologicals Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Indian Immunologicals Main Business Overview
13.3.5 Indian Immunologicals Latest Developments
13.4 Merial
13.4.1 Merial Company Information
13.4.2 Merial Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.4.3 Merial Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merial Main Business Overview
13.4.5 Merial Latest Developments
13.5 Boehringer Ingleheim Vetmedica
13.5.1 Boehringer Ingleheim Vetmedica Company Information
13.5.2 Boehringer Ingleheim Vetmedica Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.5.3 Boehringer Ingleheim Vetmedica Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Boehringer Ingleheim Vetmedica Main Business Overview
13.5.5 Boehringer Ingleheim Vetmedica Latest Developments
13.6 Elanco
13.6.1 Elanco Company Information
13.6.2 Elanco Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.6.3 Elanco Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Elanco Main Business Overview
13.6.5 Elanco Latest Developments
13.7 MSD Animal Health
13.7.1 MSD Animal Health Company Information
13.7.2 MSD Animal Health Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.7.3 MSD Animal Health Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MSD Animal Health Main Business Overview
13.7.5 MSD Animal Health Latest Developments
13.8 Biogenesis Bago
13.8.1 Biogenesis Bago Company Information
13.8.2 Biogenesis Bago Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.8.3 Biogenesis Bago Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biogenesis Bago Main Business Overview
13.8.5 Biogenesis Bago Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.9.3 Virbac Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Heska
13.10.1 Heska Company Information
13.10.2 Heska Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.10.3 Heska Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Heska Main Business Overview
13.10.5 Heska Latest Developments
13.11 Hipra
13.11.1 Hipra Company Information
13.11.2 Hipra Rabies Virus Vaccine for Pets Product Portfolios and Specifications
13.11.3 Hipra Rabies Virus Vaccine for Pets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hipra Main Business Overview
13.11.5 Hipra Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rabies Virus Vaccine for Pets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rabies Virus Vaccine for Pets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Inactivated Virus Vaccine
Table 4. Major Players of Modified Live Virus Vaccine
Table 5. Major Players of Recombinant Vaccine
Table 6. Major Players of Others
Table 7. Global Rabies Virus Vaccine for Pets Sales by Type (2018-2023) & (K Units)
Table 8. Global Rabies Virus Vaccine for Pets Sales Market Share by Type (2018-2023)
Table 9. Global Rabies Virus Vaccine for Pets Revenue by Type (2018-2023) & ($ million)
Table 10. Global Rabies Virus Vaccine for Pets Revenue Market Share by Type (2018-2023)
Table 11. Global Rabies Virus Vaccine for Pets Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Rabies Virus Vaccine for Pets Sales by Application (2018-2023) & (K Units)
Table 13. Global Rabies Virus Vaccine for Pets Sales Market Share by Application (2018-2023)
Table 14. Global Rabies Virus Vaccine for Pets Revenue by Application (2018-2023)
Table 15. Global Rabies Virus Vaccine for Pets Revenue Market Share by Application (2018-2023)
Table 16. Global Rabies Virus Vaccine for Pets Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Rabies Virus Vaccine for Pets Sales by Company (2018-2023) & (K Units)
Table 18. Global Rabies Virus Vaccine for Pets Sales Market Share by Company (2018-2023)
Table 19. Global Rabies Virus Vaccine for Pets Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Rabies Virus Vaccine for Pets Revenue Market Share by Company (2018-2023)
Table 21. Global Rabies Virus Vaccine for Pets Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Rabies Virus Vaccine for Pets Producing Area Distribution and Sales Area
Table 23. Players Rabies Virus Vaccine for Pets Products Offered
Table 24. Rabies Virus Vaccine for Pets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rabies Virus Vaccine for Pets Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Rabies Virus Vaccine for Pets Sales Market Share Geographic Region (2018-2023)
Table 29. Global Rabies Virus Vaccine for Pets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Rabies Virus Vaccine for Pets Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Rabies Virus Vaccine for Pets Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Rabies Virus Vaccine for Pets Sales Market Share by Country/Region (2018-2023)
Table 33. Global Rabies Virus Vaccine for Pets Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Rabies Virus Vaccine for Pets Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Rabies Virus Vaccine for Pets Sales by Country (2018-2023) & (K Units)
Table 36. Americas Rabies Virus Vaccine for Pets Sales Market Share by Country (2018-2023)
Table 37. Americas Rabies Virus Vaccine for Pets Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Rabies Virus Vaccine for Pets Revenue Market Share by Country (2018-2023)
Table 39. Americas Rabies Virus Vaccine for Pets Sales by Type (2018-2023) & (K Units)
Table 40. Americas Rabies Virus Vaccine for Pets Sales by Application (2018-2023) & (K Units)
Table 41. APAC Rabies Virus Vaccine for Pets Sales by Region (2018-2023) & (K Units)
Table 42. APAC Rabies Virus Vaccine for Pets Sales Market Share by Region (2018-2023)
Table 43. APAC Rabies Virus Vaccine for Pets Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Rabies Virus Vaccine for Pets Revenue Market Share by Region (2018-2023)
Table 45. APAC Rabies Virus Vaccine for Pets Sales by Type (2018-2023) & (K Units)
Table 46. APAC Rabies Virus Vaccine for Pets Sales by Application (2018-2023) & (K Units)
Table 47. Europe Rabies Virus Vaccine for Pets Sales by Country (2018-2023) & (K Units)
Table 48. Europe Rabies Virus Vaccine for Pets Sales Market Share by Country (2018-2023)
Table 49. Europe Rabies Virus Vaccine for Pets Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Rabies Virus Vaccine for Pets Revenue Market Share by Country (2018-2023)
Table 51. Europe Rabies Virus Vaccine for Pets Sales by Type (2018-2023) & (K Units)
Table 52. Europe Rabies Virus Vaccine for Pets Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Rabies Virus Vaccine for Pets Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Rabies Virus Vaccine for Pets Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rabies Virus Vaccine for Pets Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Rabies Virus Vaccine for Pets Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Rabies Virus Vaccine for Pets Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Rabies Virus Vaccine for Pets Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Rabies Virus Vaccine for Pets
Table 60. Key Market Challenges & Risks of Rabies Virus Vaccine for Pets
Table 61. Key Industry Trends of Rabies Virus Vaccine for Pets
Table 62. Rabies Virus Vaccine for Pets Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Rabies Virus Vaccine for Pets Distributors List
Table 65. Rabies Virus Vaccine for Pets Customer List
Table 66. Global Rabies Virus Vaccine for Pets Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Rabies Virus Vaccine for Pets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Rabies Virus Vaccine for Pets Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Rabies Virus Vaccine for Pets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Rabies Virus Vaccine for Pets Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Rabies Virus Vaccine for Pets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Rabies Virus Vaccine for Pets Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Rabies Virus Vaccine for Pets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Rabies Virus Vaccine for Pets Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Rabies Virus Vaccine for Pets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Rabies Virus Vaccine for Pets Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Rabies Virus Vaccine for Pets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Rabies Virus Vaccine for Pets Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Rabies Virus Vaccine for Pets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Merck Animal Health Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Animal Health Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 82. Merck Animal Health Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Merck Animal Health Main Business
Table 84. Merck Animal Health Latest Developments
Table 85. Zoetis Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 86. Zoetis Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 87. Zoetis Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Zoetis Main Business
Table 89. Zoetis Latest Developments
Table 90. Indian Immunologicals Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 91. Indian Immunologicals Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 92. Indian Immunologicals Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Indian Immunologicals Main Business
Table 94. Indian Immunologicals Latest Developments
Table 95. Merial Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 96. Merial Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 97. Merial Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Merial Main Business
Table 99. Merial Latest Developments
Table 100. Boehringer Ingleheim Vetmedica Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 101. Boehringer Ingleheim Vetmedica Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 102. Boehringer Ingleheim Vetmedica Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Boehringer Ingleheim Vetmedica Main Business
Table 104. Boehringer Ingleheim Vetmedica Latest Developments
Table 105. Elanco Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 106. Elanco Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 107. Elanco Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Elanco Main Business
Table 109. Elanco Latest Developments
Table 110. MSD Animal Health Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 111. MSD Animal Health Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 112. MSD Animal Health Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. MSD Animal Health Main Business
Table 114. MSD Animal Health Latest Developments
Table 115. Biogenesis Bago Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 116. Biogenesis Bago Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 117. Biogenesis Bago Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Biogenesis Bago Main Business
Table 119. Biogenesis Bago Latest Developments
Table 120. Virbac Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 121. Virbac Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 122. Virbac Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Virbac Main Business
Table 124. Virbac Latest Developments
Table 125. Heska Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 126. Heska Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 127. Heska Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Heska Main Business
Table 129. Heska Latest Developments
Table 130. Hipra Basic Information, Rabies Virus Vaccine for Pets Manufacturing Base, Sales Area and Its Competitors
Table 131. Hipra Rabies Virus Vaccine for Pets Product Portfolios and Specifications
Table 132. Hipra Rabies Virus Vaccine for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Hipra Main Business
Table 134. Hipra Latest Developments
List of Figures
Figure 1. Picture of Rabies Virus Vaccine for Pets
Figure 2. Rabies Virus Vaccine for Pets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Virus Vaccine for Pets Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rabies Virus Vaccine for Pets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rabies Virus Vaccine for Pets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Inactivated Virus Vaccine
Figure 10. Product Picture of Modified Live Virus Vaccine
Figure 11. Product Picture of Recombinant Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Rabies Virus Vaccine for Pets Sales Market Share by Type in 2022
Figure 14. Global Rabies Virus Vaccine for Pets Revenue Market Share by Type (2018-2023)
Figure 15. Rabies Virus Vaccine for Pets Consumed in Household Use
Figure 16. Global Rabies Virus Vaccine for Pets Market: Household Use (2018-2023) & (K Units)
Figure 17. Rabies Virus Vaccine for Pets Consumed in Commercial Use
Figure 18. Global Rabies Virus Vaccine for Pets Market: Commercial Use (2018-2023) & (K Units)
Figure 19. Global Rabies Virus Vaccine for Pets Sales Market Share by Application (2022)
Figure 20. Global Rabies Virus Vaccine for Pets Revenue Market Share by Application in 2022
Figure 21. Rabies Virus Vaccine for Pets Sales Market by Company in 2022 (K Units)
Figure 22. Global Rabies Virus Vaccine for Pets Sales Market Share by Company in 2022
Figure 23. Rabies Virus Vaccine for Pets Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Rabies Virus Vaccine for Pets Revenue Market Share by Company in 2022
Figure 25. Global Rabies Virus Vaccine for Pets Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Rabies Virus Vaccine for Pets Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Rabies Virus Vaccine for Pets Sales 2018-2023 (K Units)
Figure 28. Americas Rabies Virus Vaccine for Pets Revenue 2018-2023 ($ Millions)
Figure 29. APAC Rabies Virus Vaccine for Pets Sales 2018-2023 (K Units)
Figure 30. APAC Rabies Virus Vaccine for Pets Revenue 2018-2023 ($ Millions)
Figure 31. Europe Rabies Virus Vaccine for Pets Sales 2018-2023 (K Units)
Figure 32. Europe Rabies Virus Vaccine for Pets Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Rabies Virus Vaccine for Pets Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Rabies Virus Vaccine for Pets Revenue 2018-2023 ($ Millions)
Figure 35. Americas Rabies Virus Vaccine for Pets Sales Market Share by Country in 2022
Figure 36. Americas Rabies Virus Vaccine for Pets Revenue Market Share by Country in 2022
Figure 37. Americas Rabies Virus Vaccine for Pets Sales Market Share by Type (2018-2023)
Figure 38. Americas Rabies Virus Vaccine for Pets Sales Market Share by Application (2018-2023)
Figure 39. United States Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Rabies Virus Vaccine for Pets Sales Market Share by Region in 2022
Figure 44. APAC Rabies Virus Vaccine for Pets Revenue Market Share by Regions in 2022
Figure 45. APAC Rabies Virus Vaccine for Pets Sales Market Share by Type (2018-2023)
Figure 46. APAC Rabies Virus Vaccine for Pets Sales Market Share by Application (2018-2023)
Figure 47. China Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Rabies Virus Vaccine for Pets Sales Market Share by Country in 2022
Figure 55. Europe Rabies Virus Vaccine for Pets Revenue Market Share by Country in 2022
Figure 56. Europe Rabies Virus Vaccine for Pets Sales Market Share by Type (2018-2023)
Figure 57. Europe Rabies Virus Vaccine for Pets Sales Market Share by Application (2018-2023)
Figure 58. Germany Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Rabies Virus Vaccine for Pets Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Rabies Virus Vaccine for Pets Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Rabies Virus Vaccine for Pets Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Rabies Virus Vaccine for Pets Sales Market Share by Application (2018-2023)
Figure 67. Egypt Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Rabies Virus Vaccine for Pets Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Rabies Virus Vaccine for Pets in 2022
Figure 73. Manufacturing Process Analysis of Rabies Virus Vaccine for Pets
Figure 74. Industry Chain Structure of Rabies Virus Vaccine for Pets
Figure 75. Channels of Distribution
Figure 76. Global Rabies Virus Vaccine for Pets Sales Market Forecast by Region (2024-2029)
Figure 77. Global Rabies Virus Vaccine for Pets Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Rabies Virus Vaccine for Pets Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Rabies Virus Vaccine for Pets Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Rabies Virus Vaccine for Pets Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Rabies Virus Vaccine for Pets Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のペット用狂犬病ウイルスワクチン市場予測 2023年-2029年] (コード：LP23DC04325)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のペット用狂犬病ウイルスワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の経口狂犬病ワクチン市場予測 2023年-2029年
  • 世界の牛疫ウイルスワクチン市場予測 2023年-2029年
  • 世界の動物インフルエンザワクチン市場予測 2023年-2029年
  • 世界のウシロタウイルスワクチン市場予測 2023年-2029年
  • 世界の豚連鎖球菌ワクチン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆